AUTODERM Joins Lablab NEXT AI Accelerator Program, Leading the Future of AI-Driven Dermatology
BARCELONA/STOCKHOLM, 24th July 2024 — AUTODERM is proud to announce its participation in the Lablab NEXT AI Accelerator program, which kicks off on August 26. As a pioneering force in AI-driven dermatologic analytics, AUTODERM is set to further revolutionize how skin diseases are screened at scale. Making advanced diagnostic support widely accessible to both healthcare professionals and the general public. This will speed up diagnosing and correct treatment from the beginning by healthcare providers.
Our innovative Autoderm® API is designed to be highly adaptable, seamlessly integrating into numerous platforms, including electronic healthcare records, blogs, websites, and mobile applications. This versatility ensures that our advanced dermatologic solutions can reach a broad audience, promoting better skin health worldwide.
Founded by Dr. Alexander Börve, MD, and Lucas Thil, AUTODERM is dedicated to merging technology with healthcare to enhance diagnostic processes and workflows. Our "two founder team" has already made a significant impact, identifying melanomas in 5% of the UK population.
“We are thrilled to join the Lablab NEXT AI Accelerator program and expand the reach of our innovative solutions. With over 50% of the global population lacking access to basic healthcare and 30% of individuals facing social exclusion due to skin diseases, our mission is to provide inclusiveness and accessibility for everyone, regardless of skin color, age, or gender.” - Dr. Alexander Börve
As we embark on this exciting journey with the support of the Lablab NEXT AI Accelerator program, AUTODERM is poised to make significant strides in the global healthcare landscape. By leveraging AI to provide reliable and accessible dermatologic AI; we are unlocking superpowers in dermatology and making a positive impact on millions of lives worldwide.
About AUTODERM
AUTODERM is a clinical research backed artificial intelligence (AI) dermatology analytics engine, CE marked and registered with the MHRA. With a proprietary database of amateur smartphone images of skin diseases, they make AI models in dermatology. The AI models are accessible via an API and can be integrated into any platform. The intended use is as a decision support tool for healthcare providers and a triage / informational tool for the layman.
About Lablab NEXT AI Accelerator Program
The Lablab NEXT AI Accelerator program is dedicated to supporting innovative startups that harness the power of artificial intelligence to create transformative solutions in various industries. Through mentorship, resources, and strategic guidance, we empower participants to achieve their full potential and drive meaningful advancements in their respective fields.
BARCELONA/STOCKHOLM, 24th July 2024 — AUTODERM is proud to announce its participation in the Lablab NEXT AI Accelerator program, which kicks off on August 26. As a pioneering force in AI-driven dermatologic analytics, AUTODERM is set to further revolutionize how skin diseases are screened at scale. Making advanced diagnostic support widely accessible to both healthcare professionals and the general public. This will speed up diagnosing and correct treatment from the beginning by healthcare providers.
Our innovative Autoderm® API is designed to be highly adaptable, seamlessly integrating into numerous platforms, including electronic healthcare records, blogs, websites, and mobile applications. This versatility ensures that our advanced dermatologic solutions can reach a broad audience, promoting better skin health worldwide.
Founded by Dr. Alexander Börve, MD, and Lucas Thil, AUTODERM is dedicated to merging technology with healthcare to enhance diagnostic processes and workflows. Our "two founder team" has already made a significant impact, identifying melanomas in 5% of the UK population.
“We are thrilled to join the Lablab NEXT AI Accelerator program and expand the reach of our innovative solutions. With over 50% of the global population lacking access to basic healthcare and 30% of individuals facing social exclusion due to skin diseases, our mission is to provide inclusiveness and accessibility for everyone, regardless of skin color, age, or gender.” - Dr. Alexander Börve
As we embark on this exciting journey with the support of the Lablab NEXT AI Accelerator program, AUTODERM is poised to make significant strides in the global healthcare landscape. By leveraging AI to provide reliable and accessible dermatologic AI; we are unlocking superpowers in dermatology and making a positive impact on millions of lives worldwide.
About AUTODERM
AUTODERM is a clinical research backed artificial intelligence (AI) dermatology analytics engine, CE marked and registered with the MHRA. With a proprietary database of amateur smartphone images of skin diseases, they make AI models in dermatology. The AI models are accessible via an API and can be integrated into any platform. The intended use is as a decision support tool for healthcare providers and a triage / informational tool for the layman.
About Lablab NEXT AI Accelerator Program
The Lablab NEXT AI Accelerator program is dedicated to supporting innovative startups that harness the power of artificial intelligence to create transformative solutions in various industries. Through mentorship, resources, and strategic guidance, we empower participants to achieve their full potential and drive meaningful advancements in their respective fields.
